Kroin David's Form 4 filing
LB Pharmaceuticals Inc (LBRX) · filed Sep 16, 2025
- Accession no.
- 0002015536-25-000007
- Filed
- Sep 16, 2025, 6:09 PM ET
- Trade date
- Sep 12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $40.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kroin DavidCIK 0001397513 | 10% Owner |
| Deep Track Capital, LPCIK 0001856083 | 10% Owner |
| Deep Track Biotechnology Master Fund, Ltd.CIK 0002015536 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Common Stock | CConversionAcquired | +686,138 | – | – | 686,138 | Direct | |
| Sep 12, 2025 | Common Stock | PPurchaseAcquired | +2,000,000 | $15.00 | +$30,000,000 | 2,686,138 | Direct | |
| Sep 12, 2025 | Common Stock | PPurchaseAcquired | +666,666 | $15.00 | +$9,999,990 | 666,666 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Common Stock | CConversionDisposed | −686,138 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.